TotalMarketCap

Pelthos Therapeutics

PTHSNYSE United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$36.743 M

$9.35 -7.93%

Close of 6 Nov 2026

As of 6 Nov 2026, Pelthos Therapeutics (PTHS) has a market capitalization of $36.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$16.8M

#3022 by revenue

Earnings

-$43.3M

Loss-making

Shares outstanding

3,828,469

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #130ExozymesEXOZ$38.2M
  2. #131Inmune BioINMB$36.8M
  3. #132Pelthos TherapeuticsPTHS$36.7M
  4. #133ElutiaELUT$34.7M
  5. #134Aligos TherapeuticsALGS$28.6M

What if Pelthos Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$7,181,613

Per share 768,498× higher

Bitcoin $1.53T

$388,584.57

Per share 41,582× higher

Apple $5.02T

$1,275,687

Per share 136,510× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Pelthos Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.